目的：探究局部晚期宫颈癌患者在新辅助化疗后应用机器人辅助下腹腔镜手术与开腹手术治疗后术 后生存质量的差异，并对其影响因素进行分析。方法：对 2016 年 1 月—2016 年 12 月在南昌大学第一附属医院妇科 接受治疗的 76 例宫颈癌患者进行回顾性研究。其中研究组为机器人手术组，38 例患者全部于新辅助化疗结束后行 机器人辅助腹腔镜下广泛性子宫切除术及盆腔淋巴结清扫术；对照组为开腹手术组，38 例患者在新辅助化疗结束后 行开腹下广泛性子宫切除术及盆腔淋巴结清扫术；两组均对部分患者行腹主动脉旁淋巴结取样。纳入研究对象的一 般临床特征、术后手术质量评价指标并统计和分析其无进展生存期及总生存期。结果：研究组与对照组的一般临床 特征无差异，但研究组术后多项手术质量评价指标与对照组均有统计学差异（P<0.05）。两组病理预后因素、无病 生存期、总生存期、3 年生存率和 5 年生存率比较，差异无统计学意义（P>0.05）；经单因素和多因素 Cox 比例风 险模型分析发现，宫颈浸润程度和术后是否补充放化疗为预后独立危险因素。结论：对于局部晚期宫颈癌患者，机 器人辅助腹腔镜手术比传统开腹手术的手术质量评价好，但两者在患者病理预后因素及术后生存期上无明显差异。

Objective: To explore the differences of postoperative survival between patients underwent robot-assisted laparoscopic surgery and conventional laparotomy for locally advanced cervical cancer after neoadjuvant chemotherapy. Methods: A retrospective study was performed on 76 patients with cervical cancer who were treated in the Department of Gynecology, the First Affiliated Hospital of Nanchang University from January 2016 to December 2016. Among which, 38 patients underwent robot-assisted laparoscopic radical hysterectomy and pelvic lymph node dissection after neoadjuvant chemotherapy were divided into the study group, and 38 patients who were treated with conventional laparotomy after neoadjuvant chemotherapy into the control group. There was part of patients underwent para-aortic lymph node sampling in both groups. Results: There was no difference in terms of the general clinical characteristics between the two groups, but significant differences on surgical quality evaluation indicators were found between the two groups (P<0.05). There was no significant difference in pathological prognostic factors, disease-free survival, overall survival, 3-year survival rate, and 5-year survival rate (P>0.05). Doing chemoradiotherapy or not after surgery was an independent prognostic risk factor. Conclusion: For patients with locally advanced cervical cancer, robotassisted surgery has better evaluation of surgical quality after surgery than the conventional laparotomy, but no significant difference was found in terms of pathological prognostic factors and postoperative survival between the two ways.

收稿日期：2022-04-29  录用日期：2022-11-31 

Received Date: 2022-04-29  Accepted Date: 2022-11-31 

基金项目：江西省自然科学基金（20192ACBL20038）；江西省科技计划重大项目（20152ACG70022） 

Foundation Item: Natural Science Foundation of Jiangxi Province(20192ACBL20038); Major Science and Technology Project of Jiangxi Province(20152ACG70022) 

通讯作者：蔡丽萍，E-mail：cailiping2550@163.com 

Corresponding Author: CAI Liping, E-mail: cailiping2550@163.com 

引用格式：周潇妮，唐旭秀，蔡丽萍，等 . 新辅助化疗后机器人辅助与开腹手术治疗局部晚期子宫颈癌术后生存影响因素的对比 分析 [J]. 机器人外科学杂志（中英文），2024，5（2）：178-185. 

Citation: ZHOU X N, TANG X X, CAI L P, et al. Comparative analysis of the influencing factors on postoperative survival between robotic surgery and conventional laparotomy for locally advanced cervical cancer after neoadjuvant chemotherapy [J].Chinese Journal of Robotic Surgery, 2024, 5(2): 178-185

[1] Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis [J]. Lancet Glob Health, 2020, 8(2): 191-203. 

[2] Hill E K. Updates in cervical cancer treatment [J]. Clin Obstet Gynecol, 2020, 63(1): 3-11. 

[3] Gadducci A, Cosio S. Neoadjuvant chemotherapy in locally advanced cervical cancer: review of the literature and perspectives of clinical research [J]. Anticancer Res, 2020, 40(9): 4819-4828. 

[4] Peters B S, Armijo P R, Krause C, et al. Review of emerging surgical robotic technology [J]. Surg Endosc, 2018, 32(4): 1636-1655. 

[5] Armijo P R, Pagkratis S, Boilesen E, et al. Growth in robotic-assisted procedures is from conversion of laparoscopic procedures and not from open surgeons’ conversion: a study of trends and costs [J]. Surg Endosc, 2018, 32(4): 2106-2113. 

[6] Leal G T, Campos C O. 30 Years of robotic surgery [J]. World J Surg, 2016, 40(10): 2550-2557. 

[7] Peters B S, Armijo P R, Krause C, et al. Review of emerging surgical robotic technology [J]. Surg Endosc, 2018, 32(4): 1636-1655. 

[8] 齐金红 , 袁勇 , 冯文娟 , 等 . 达芬奇机器人在妇科 手术应用中的安全性评价 [J]. 机器人外科学杂志 ( 中英文 ), 2021, 2(2): 111-122. 

[9] CAO L, XU H, CHEN Y, et al. A detailed analysis of the learning curve: da vinci robot-assisted radical hysterectomy in cervical cancer [J]. J Minim Invasive Gynecol, 2015, 22(6S): S228-S229. 

[10] 温晓春 , 蔡丽萍 , 涂春华 , 等 . 达芬奇机器人手术 系统在妇科肿瘤手术中的应用 [J]. 南昌大学学报 ( 医学版 ), 2016, 56(6): 60-62. 

[11] Sponholtz S E, Mogensen O, Hildebrandt M G, et al. From FIGO-2009 to FIGO-2018 in women with earlystage cervical cancer; does the revised staging reflect risk groups?[J]. Gynecol Oncol, 2021, 163(2): 281-288. 

[12] 张仲华 , 刘晨瑛 , 任会叶 , 等 . 2003-2018 年间中国 女性宫颈癌发病与死亡趋势研究 [J]. 中华疾病控制 杂志 , 2022, 26(1): 14-20. 

[13] Johnson C A, James D, Marzan A, et al. Cervical cancer: an overview of pathophysiology and management [J]. Semin Oncol Nurs, 2019, 35(2): 166-174. 

[14] Stier E A, Engels E, Horner M J, et al. Cervical cancer incidence stratified by age in women with HIV compared with the general population in the United States, 2002-2016 [J]. AIDS, 2021, 35(11): 1851-1856. 

[15] 徐萍萍 . 广泛性子宫切除术前行新辅助化疗对 IB2 及 IIA2 期宫颈癌的治疗影响 [D]. 大连 : 大连医科大 学 , 2019: 1-8.